Hamilton Thorne Management

How experienced are the management team and are they aligned to shareholders interests?

6.3yrs

Average management tenure


CEO

David Wolf

11.17yrs

Tenure

US$553,613

Compensation

Mr. David B. Wolf has been the Chief Executive Officer and President of Hamilton Thorne Ltd. since September 2011 and serves as its Chair since January 18, 2022. From October 1997 to August 2011, Mr. Wolf...


CEO Compensation Analysis

How has David Wolf's remuneration changed compared to Hamilton Thorne's earnings?
DateTotal Comp.SalaryCompany Earnings
Sep 30 2022n/an/a

US$2m

Jun 30 2022n/an/a

US$2m

Mar 31 2022n/an/a

US$2m

Dec 31 2021US$554kUS$350k

US$2m

Sep 30 2021n/an/a

US$3m

Jun 30 2021n/an/a

US$3m

Mar 31 2021n/an/a

US$2m

Dec 31 2020US$413kUS$302k

US$971k

Sep 30 2020n/an/a

US$941k

Jun 30 2020n/an/a

US$808k

Mar 31 2020n/an/a

US$2m

Dec 31 2019US$438kUS$302k

US$793k

Sep 30 2019n/an/a

US$3m

Jun 30 2019n/an/a

US$2m

Mar 31 2019n/an/a

US$2m

Dec 31 2018US$467kUS$295k

US$3m

Sep 30 2018n/an/a

US$5m

Jun 30 2018n/an/a

US$6m

Mar 31 2018n/an/a

US$6m

Dec 31 2017US$459kUS$214k

US$6m

Sep 30 2017n/an/a

US$2m

Jun 30 2017n/an/a

US$970k

Mar 31 2017n/an/a

US$1m

Dec 31 2016US$303kUS$209k

US$679k

Sep 30 2016n/an/a

US$553k

Jun 30 2016n/an/a

US$734k

Mar 31 2016n/an/a

US$915k

Dec 31 2015US$279kUS$205k

US$1m

Compensation vs Market: David's total compensation ($USD553.61K) is about average for companies of similar size in the Canadian market ($USD753.76K).

Compensation vs Earnings: David's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.


Leadership Team

NamePositionTenureCompensationOwnership
David Wolf
Chair, President & CEO11.17yrsUS$553.61k1.82%
$ 3.8m
Diarmaid Douglas-Hamilton
Co-Founder25.83yrsUS$188.12k0.90%
$ 1.9m
Brett Fulton
Senior VP & GM1.5yrsUS$235.55kno data
Francesco Fragasso
Chief Financial Officer0.17yrno datano data
Justin Jaundoo
Vice President of Corporate Developmentno datano datano data
Eric Dorman
President of Embryotech Laboratories Incno dataUS$215.25kno data
Fabian Sell
Chief Executive Officer of Gynemedno dataUS$282.51kno data
Joel Lopez
President of Embryotech Laboratoriesno datano datano data

6.3yrs

Average Tenure

Experienced Management: HTL's management team is seasoned and experienced (6.3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
David Wolf
Chair, President & CEO11.17yrsUS$553.61k1.82%
$ 3.8m
Robert Potter
Lead Independent Director13.08yrsUS$47.50k0.26%
$ 541.7k
Daniel Thorne
Independent Director13.08yrsno data13.92%
$ 29.0m
Bruno Maruzzo
Independent Director15.67yrsUS$47.50k0.12%
$ 258.0k
Karen Firestone
Independent Director0.83yrno data0.016%
$ 33.1k
David Sable
Independent Director5.75yrsno data0.047%
$ 97.4k
Marc Robinson
Independent Director1.83yrsno data0.012%
$ 24.7k
Meg Spencer
Chairman Emeritus0.33yrUS$37.50k0.98%
$ 2.0m
Cynthia Hudson
Member of Scientific Advisory Board1.58yrsno datano data
Feng Han
Independent Director1.75yrsUS$37.50k0.013%
$ 27.6k
Thomas Ebner
Member of Scientific Advisory Board1.58yrsno datano data
David Mortimer
Member of Scientific Advisory Boardno datano datano data

1.8yrs

Average Tenure

70yo

Average Age

Experienced Board: HTL's board of directors are not considered experienced ( 1.8 years average tenure), which suggests a new board.